

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.40694045 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.09171783 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.76332172 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.76332172 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46586759 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.21138315 |
| 7 | response to interferon-beta (GO:0035456) | 3.87752733 |
| 8 | detection of other organism (GO:0098543) | 3.84490517 |
| 9 | detection of bacterium (GO:0016045) | 3.82687833 |
| 10 | cellular response to type I interferon (GO:0071357) | 3.81410829 |
| 11 | type I interferon signaling pathway (GO:0060337) | 3.81410829 |
| 12 | response to type I interferon (GO:0034340) | 3.78042586 |
| 13 | barbed-end actin filament capping (GO:0051016) | 3.72855034 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 3.67394472 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.67263908 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.67263908 |
| 17 | positive regulation of protein homooligomerization (GO:0032464) | 3.61323754 |
| 18 | response to interferon-alpha (GO:0035455) | 3.59148670 |
| 19 | cellular response to interferon-beta (GO:0035458) | 3.57177593 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.48339328 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.48339328 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.48339328 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.48339328 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.48339328 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.48339328 |
| 26 | ribosomal small subunit assembly (GO:0000028) | 3.44922797 |
| 27 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40324779 |
| 28 | pinocytosis (GO:0006907) | 3.39897852 |
| 29 | proline biosynthetic process (GO:0006561) | 3.38015546 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.34940251 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28440666 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.20519748 |
| 33 | negative regulation of viral genome replication (GO:0045071) | 3.15998779 |
| 34 | B cell mediated immunity (GO:0019724) | 3.14163310 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13680514 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.12764776 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.12475553 |
| 38 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.11950625 |
| 39 | mature B cell differentiation involved in immune response (GO:0002313) | 3.11776290 |
| 40 | respiratory burst (GO:0045730) | 3.10433648 |
| 41 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09132091 |
| 42 | response to peptidoglycan (GO:0032494) | 3.08560253 |
| 43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03887396 |
| 44 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.02726307 |
| 45 | regulation of leukocyte degranulation (GO:0043300) | 3.02292815 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00430597 |
| 47 | regulation of interferon-alpha production (GO:0032647) | 2.99748341 |
| 48 | defense response to protozoan (GO:0042832) | 2.99131987 |
| 49 | neutrophil activation (GO:0042119) | 2.95513741 |
| 50 | positive regulation of antigen processing and presentation (GO:0002579) | 2.95496846 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.94495940 |
| 52 | cellular extravasation (GO:0045123) | 2.92268338 |
| 53 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.91168242 |
| 54 | NIK/NF-kappaB signaling (GO:0038061) | 2.90183970 |
| 55 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.88911236 |
| 56 | negative regulation of phagocytosis (GO:0050765) | 2.88851479 |
| 57 | positive regulation of lamellipodium assembly (GO:0010592) | 2.88660507 |
| 58 | granulocyte activation (GO:0036230) | 2.87219380 |
| 59 | amino sugar catabolic process (GO:0046348) | 2.82538726 |
| 60 | regulation of integrin activation (GO:0033623) | 2.82120535 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80911789 |
| 62 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.79803974 |
| 63 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.78081154 |
| 64 | embryonic process involved in female pregnancy (GO:0060136) | 2.78021241 |
| 65 | cellular response to virus (GO:0098586) | 2.77820789 |
| 66 | viral transcription (GO:0019083) | 2.77746542 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 2.76373656 |
| 68 | response to protozoan (GO:0001562) | 2.75306645 |
| 69 | leukocyte mediated cytotoxicity (GO:0001909) | 2.73381872 |
| 70 | regulation of RIG-I signaling pathway (GO:0039535) | 2.72713179 |
| 71 | positive regulation of protein oligomerization (GO:0032461) | 2.72478386 |
| 72 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.71509695 |
| 73 | regulation of growth of symbiont in host (GO:0044126) | 2.71509695 |
| 74 | negative regulation of growth of symbiont in host (GO:0044130) | 2.71509695 |
| 75 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.71509695 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 2.71400168 |
| 77 | natural killer cell mediated immunity (GO:0002228) | 2.71113272 |
| 78 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71113272 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 2.71042191 |
| 80 | sequestering of actin monomers (GO:0042989) | 2.69523861 |
| 81 | detection of biotic stimulus (GO:0009595) | 2.68976515 |
| 82 | reactive oxygen species biosynthetic process (GO:1903409) | 2.67140122 |
| 83 | positive regulation of B cell differentiation (GO:0045579) | 2.67014232 |
| 84 | T cell migration (GO:0072678) | 2.66102473 |
| 85 | regulation of superoxide anion generation (GO:0032928) | 2.65970413 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.65965458 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 2.65965458 |
| 88 | positive regulation of interferon-beta production (GO:0032728) | 2.64732610 |
| 89 | myeloid dendritic cell differentiation (GO:0043011) | 2.63280396 |
| 90 | fibril organization (GO:0097435) | 2.63110723 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62870689 |
| 92 | response to host immune response (GO:0052572) | 2.62870689 |
| 93 | translational termination (GO:0006415) | 2.62312271 |
| 94 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62275616 |
| 95 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.61847219 |
| 96 | lipoxygenase pathway (GO:0019372) | 2.60283863 |
| 97 | regulation of hypersensitivity (GO:0002883) | 2.58545676 |
| 98 | negative regulation of interleukin-12 production (GO:0032695) | 2.57247540 |
| 99 | regulation of mononuclear cell migration (GO:0071675) | 2.57240933 |
| 100 | replication fork processing (GO:0031297) | 2.56806684 |
| 101 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.55923602 |
| 102 | negative regulation of innate immune response (GO:0045824) | 2.55569609 |
| 103 | positive regulation of mast cell activation (GO:0033005) | 2.54316868 |
| 104 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.53876986 |
| 105 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53836238 |
| 106 | dendritic cell differentiation (GO:0097028) | 2.53094653 |
| 107 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52844899 |
| 108 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.52747010 |
| 109 | regulation of chemokine biosynthetic process (GO:0045073) | 2.52635824 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 2.52502131 |
| 111 | regulation of mast cell activation (GO:0033003) | 2.51313020 |
| 112 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.51285975 |
| 113 | leukocyte aggregation (GO:0070486) | 2.51129241 |
| 114 | regulation of protein homooligomerization (GO:0032462) | 2.50645036 |
| 115 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50365479 |
| 116 | telomere maintenance via recombination (GO:0000722) | 2.50072892 |
| 117 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.49965674 |
| 118 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49208617 |
| 119 | response to host (GO:0075136) | 2.49208617 |
| 120 | response to host defenses (GO:0052200) | 2.49208617 |
| 121 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47543145 |
| 122 | cellular response to exogenous dsRNA (GO:0071360) | 2.47090785 |
| 123 | pyrimidine nucleoside salvage (GO:0043097) | 2.46919074 |
| 124 | pyrimidine-containing compound salvage (GO:0008655) | 2.46919074 |
| 125 | proline metabolic process (GO:0006560) | 2.46732998 |
| 126 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.46512350 |
| 127 | response to muramyl dipeptide (GO:0032495) | 2.46360996 |
| 128 | regulation of natural killer cell differentiation (GO:0032823) | 2.46096359 |
| 129 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45573295 |
| 130 | glycosphingolipid catabolic process (GO:0046479) | 2.45467438 |
| 131 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.45272542 |
| 132 | actin nucleation (GO:0045010) | 2.45235054 |
| 133 | negative regulation of interleukin-6 production (GO:0032715) | 2.45194502 |
| 134 | pentose-phosphate shunt (GO:0006098) | 2.45099497 |
| 135 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.44385986 |
| 136 | regulation of activation of Janus kinase activity (GO:0010533) | 2.44070738 |
| 137 | positive regulation of T cell apoptotic process (GO:0070234) | 2.43555524 |
| 138 | transcription from mitochondrial promoter (GO:0006390) | 2.43458977 |
| 139 | T-helper 1 type immune response (GO:0042088) | 2.43120594 |
| 140 | regulation of monocyte chemotaxis (GO:0090025) | 2.42779774 |
| 141 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.42674799 |
| 142 | * regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.42533328 |
| 143 | positive regulation of leukocyte degranulation (GO:0043302) | 2.41950499 |
| 144 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.41039428 |
| 145 | formation of translation preinitiation complex (GO:0001731) | 2.40885551 |
| 146 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.40858144 |
| 147 | macrophage differentiation (GO:0030225) | 2.39569202 |
| 148 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.39283288 |
| 149 | positive regulation of lamellipodium organization (GO:1902745) | 2.39035804 |
| 150 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.38268673 |
| 151 | leukocyte degranulation (GO:0043299) | 2.37958930 |
| 152 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.37673183 |
| 153 | low-density lipoprotein particle clearance (GO:0034383) | 2.37355176 |
| 154 | negative regulation of granulocyte differentiation (GO:0030853) | 2.37197756 |
| 155 | regulation of macrophage chemotaxis (GO:0010758) | 2.36428216 |
| 156 | protein localization to endosome (GO:0036010) | 2.36153686 |
| 157 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.34915790 |
| 158 | protein targeting to ER (GO:0045047) | 2.32153666 |
| 159 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.31942438 |
| 160 | regulation of necroptotic process (GO:0060544) | 2.31668541 |
| 161 | cotranslational protein targeting to membrane (GO:0006613) | 2.30665569 |
| 162 | translational elongation (GO:0006414) | 2.30616670 |
| 163 | positive regulation of macrophage differentiation (GO:0045651) | 2.30120636 |
| 164 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.30043281 |
| 165 | leukocyte cell-cell adhesion (GO:0007159) | 2.28726770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.91166830 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.90061328 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15365123 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.97962100 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92436095 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.82739223 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.58863113 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57287340 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49963887 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48891778 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41717682 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34666564 |
| 13 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.33045088 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26483673 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25965746 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15665527 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.13063395 |
| 18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10914307 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04575143 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04416333 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.99201159 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96337419 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95191049 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90813266 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90236490 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.86036628 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77541693 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.77371455 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76086303 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.70852579 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69689053 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69661030 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61535725 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59798472 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59524457 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58663795 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58157255 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.56887066 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55783828 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53905655 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.49949128 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47369278 |
| 43 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.47256799 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.45046064 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44368739 |
| 46 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44282143 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.43129399 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39757174 |
| 49 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.39561291 |
| 50 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38427342 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38283394 |
| 52 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36438050 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.35796401 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35315785 |
| 55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.34571508 |
| 56 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.33332327 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32815465 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32612627 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32346027 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30928349 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30382206 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30196807 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28989492 |
| 64 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27937261 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27881096 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27868390 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27828421 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24738540 |
| 69 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24335752 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23980701 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23904160 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23341642 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.23341021 |
| 74 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22597165 |
| 75 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22500537 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20851974 |
| 77 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19655089 |
| 78 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19564414 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 1.18836459 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17857512 |
| 81 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17580222 |
| 82 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16395749 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16166306 |
| 84 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15363044 |
| 85 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15356237 |
| 86 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14767308 |
| 87 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13664615 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13581250 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13513016 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13459014 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13292491 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12989792 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12381247 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12358083 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12310427 |
| 96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12301617 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11758260 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11652131 |
| 99 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10307313 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09823585 |
| 101 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.09471145 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09018031 |
| 103 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08756758 |
| 104 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08745675 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08590634 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06918031 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06838918 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06671828 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06657715 |
| 110 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.06198744 |
| 111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05899445 |
| 112 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.05065451 |
| 113 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04220029 |
| 114 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03612128 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02603131 |
| 116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02397870 |
| 117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01776260 |
| 118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00451217 |
| 119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99552182 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99280049 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99260434 |
| 122 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.99154228 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99016207 |
| 124 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98954999 |
| 125 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97935426 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97007821 |
| 127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96331398 |
| 128 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.94946650 |
| 129 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94609405 |
| 130 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94509082 |
| 131 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93836043 |
| 132 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93528042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.03464479 |
| 2 | MP0000685_abnormal_immune_system | 3.39262866 |
| 3 | MP0009785_altered_susceptibility_to | 3.33526990 |
| 4 | MP0003436_decreased_susceptibility_to | 2.94491589 |
| 5 | MP0003724_increased_susceptibility_to | 2.85329581 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.83255136 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.63639379 |
| 8 | MP0005025_abnormal_response_to | 2.62884558 |
| 9 | MP0005671_abnormal_response_to | 2.51238980 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.36540814 |
| 11 | MP0002006_tumorigenesis | 2.33047964 |
| 12 | MP0002419_abnormal_innate_immunity | 2.29503613 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.29013447 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.29013447 |
| 15 | MP0006082_CNS_inflammation | 2.28086440 |
| 16 | MP0005387_immune_system_phenotype | 2.26120439 |
| 17 | MP0001790_abnormal_immune_system | 2.26120439 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.24748996 |
| 19 | MP0001800_abnormal_humoral_immune | 2.10218533 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.10184089 |
| 21 | MP0002723_abnormal_immune_serum | 2.04489002 |
| 22 | MP0001853_heart_inflammation | 2.03256849 |
| 23 | MP0001819_abnormal_immune_cell | 1.98838402 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.97691853 |
| 25 | MP0002405_respiratory_system_inflammati | 1.97679755 |
| 26 | MP0009278_abnormal_bone_marrow | 1.97361262 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.90730022 |
| 28 | MP0008057_abnormal_DNA_replication | 1.87521806 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.82424664 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.81636090 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.79602318 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.79519411 |
| 33 | MP0008260_abnormal_autophagy | 1.79319531 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.78841291 |
| 35 | MP0003186_abnormal_redox_activity | 1.75395713 |
| 36 | MP0002398_abnormal_bone_marrow | 1.71809044 |
| 37 | MP0005451_abnormal_body_composition | 1.70445315 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.69584729 |
| 39 | MP0003279_aneurysm | 1.63796470 |
| 40 | MP0000716_abnormal_immune_system | 1.63193524 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.59953862 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.59636060 |
| 43 | MP0000490_abnormal_crypts_of | 1.57796346 |
| 44 | MP0000343_altered_response_to | 1.55486482 |
| 45 | MP0000858_altered_metastatic_potential | 1.55141513 |
| 46 | MP0001542_abnormal_bone_strength | 1.54722777 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.50431329 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.49345500 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.47161272 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.44765876 |
| 51 | MP0002429_abnormal_blood_cell | 1.42412207 |
| 52 | MP0008469_abnormal_protein_level | 1.41268110 |
| 53 | MP0003448_altered_tumor_morphology | 1.41104924 |
| 54 | MP0002722_abnormal_immune_system | 1.40867007 |
| 55 | MP0001958_emphysema | 1.37531971 |
| 56 | MP0004947_skin_inflammation | 1.33166258 |
| 57 | MP0009764_decreased_sensitivity_to | 1.33152104 |
| 58 | MP0003303_peritoneal_inflammation | 1.32530393 |
| 59 | MP0000604_amyloidosis | 1.30962098 |
| 60 | MP0004510_myositis | 1.28703229 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.24346904 |
| 62 | MP0001873_stomach_inflammation | 1.23545877 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.22317752 |
| 64 | MP0002009_preneoplasia | 1.22190024 |
| 65 | MP0005166_decreased_susceptibility_to | 1.21502589 |
| 66 | MP0005165_increased_susceptibility_to | 1.21088395 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 1.19546567 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.19106698 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.13017938 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.12515348 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.11855352 |
| 72 | MP0001851_eye_inflammation | 1.08198432 |
| 73 | MP0003828_pulmonary_edema | 1.01939974 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.01637069 |
| 75 | MP0003566_abnormal_cell_adhesion | 0.99963999 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.97770448 |
| 77 | MP0003075_altered_response_to | 0.97633585 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 0.96044738 |
| 79 | MP0009840_abnormal_foam_cell | 0.95267314 |
| 80 | MP0004883_abnormal_blood_vessel | 0.95018071 |
| 81 | MP0003866_abnormal_defecation | 0.92881111 |
| 82 | MP0010307_abnormal_tumor_latency | 0.92671088 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.91510005 |
| 84 | MP0003795_abnormal_bone_structure | 0.91047711 |
| 85 | MP0009763_increased_sensitivity_to | 0.90404745 |
| 86 | MP0005023_abnormal_wound_healing | 0.90292000 |
| 87 | MP0002132_abnormal_respiratory_system | 0.89949667 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.89674087 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.88626634 |
| 90 | MP0005275_abnormal_skin_tensile | 0.86971155 |
| 91 | MP0002933_joint_inflammation | 0.86200596 |
| 92 | MP0003091_abnormal_cell_migration | 0.85801827 |
| 93 | MP0005257_abnormal_intraocular_pressure | 0.84561733 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.83470507 |
| 95 | MP0009115_abnormal_fat_cell | 0.83311805 |
| 96 | MP0000371_diluted_coat_color | 0.83137099 |
| 97 | MP0004858_abnormal_nervous_system | 0.82036581 |
| 98 | MP0005310_abnormal_salivary_gland | 0.79509621 |
| 99 | MP0002796_impaired_skin_barrier | 0.79352406 |
| 100 | MP0005390_skeleton_phenotype | 0.79242332 |
| 101 | MP0006054_spinal_hemorrhage | 0.78544052 |
| 102 | MP0003329_amyloid_beta_deposits | 0.78217434 |
| 103 | MP0005164_abnormal_response_to | 0.77851711 |
| 104 | MP0003693_abnormal_embryo_hatching | 0.77439115 |
| 105 | MP0001663_abnormal_digestive_system | 0.77277248 |
| 106 | MP0001243_abnormal_dermal_layer | 0.73823810 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.73624850 |
| 108 | MP0010094_abnormal_chromosome_stability | 0.73281997 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.73149196 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.73003107 |
| 111 | MP0000249_abnormal_blood_vessel | 0.72786593 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.72113258 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.71790871 |
| 114 | MP0008004_abnormal_stomach_pH | 0.71440736 |
| 115 | MP0002060_abnormal_skin_morphology | 0.70893463 |
| 116 | MP0003786_premature_aging | 0.68671344 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.68389673 |
| 118 | MP0001849_ear_inflammation | 0.68167457 |
| 119 | MP0000750_abnormal_muscle_regeneration | 0.67929268 |
| 120 | MP0000609_abnormal_liver_physiology | 0.67371985 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67116351 |
| 122 | MP0008007_abnormal_cellular_replicative | 0.66144238 |
| 123 | MP0002163_abnormal_gland_morphology | 0.64217758 |
| 124 | MP0000598_abnormal_liver_morphology | 0.63192581 |
| 125 | MP0003077_abnormal_cell_cycle | 0.61370871 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.60539132 |
| 127 | MP0004957_abnormal_blastocyst_morpholog | 0.59635363 |
| 128 | MP0002254_reproductive_system_inflammat | 0.59225291 |
| 129 | MP0005670_abnormal_white_adipose | 0.58740564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.01156987 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.95152231 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.95152231 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.95152231 |
| 5 | Increased IgM level (HP:0003496) | 4.85226541 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.78339891 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.67336086 |
| 8 | Pustule (HP:0200039) | 4.35862796 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.25958965 |
| 10 | Myositis (HP:0100614) | 3.76867846 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.51375701 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.42139766 |
| 13 | Thrombocytosis (HP:0001894) | 3.40530620 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.37990162 |
| 15 | Chronic otitis media (HP:0000389) | 3.34400486 |
| 16 | Hypergammaglobulinemia (HP:0010702) | 3.28775773 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.25633149 |
| 18 | Amyloidosis (HP:0011034) | 3.23069382 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.20542040 |
| 20 | Abnormality of T cell physiology (HP:0011840) | 3.19660057 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.07816538 |
| 22 | Hepatosplenomegaly (HP:0001433) | 2.99787229 |
| 23 | Abnormal number of erythroid precursors (HP:0012131) | 2.97366863 |
| 24 | Recurrent skin infections (HP:0001581) | 2.96719382 |
| 25 | Poikiloderma (HP:0001029) | 2.96391872 |
| 26 | Petechiae (HP:0000967) | 2.92946689 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.91710549 |
| 28 | Loss of speech (HP:0002371) | 2.91703745 |
| 29 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.89531108 |
| 30 | Orchitis (HP:0100796) | 2.88208955 |
| 31 | Nasal polyposis (HP:0100582) | 2.73103277 |
| 32 | Obstructive lung disease (HP:0006536) | 2.72755805 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72755805 |
| 34 | Premature rupture of membranes (HP:0001788) | 2.71858217 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 2.71019213 |
| 36 | Vasculitis (HP:0002633) | 2.68246071 |
| 37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65613346 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.65613346 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.64842060 |
| 40 | Abnormality of T cells (HP:0002843) | 2.62623302 |
| 41 | Recurrent viral infections (HP:0004429) | 2.62396692 |
| 42 | Albinism (HP:0001022) | 2.59424010 |
| 43 | IgA deficiency (HP:0002720) | 2.56587532 |
| 44 | Basal ganglia calcification (HP:0002135) | 2.56101219 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.53189253 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.52430593 |
| 47 | IgG deficiency (HP:0004315) | 2.51572252 |
| 48 | Exertional dyspnea (HP:0002875) | 2.51344779 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.49858682 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.49858682 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.48519186 |
| 52 | IgM deficiency (HP:0002850) | 2.46789865 |
| 53 | Gingivitis (HP:0000230) | 2.44104302 |
| 54 | Periodontitis (HP:0000704) | 2.42246356 |
| 55 | Protrusio acetabuli (HP:0003179) | 2.40926380 |
| 56 | Distal lower limb muscle weakness (HP:0009053) | 2.39706939 |
| 57 | Abnormal hemoglobin (HP:0011902) | 2.38444281 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.38116055 |
| 59 | Urticaria (HP:0001025) | 2.35379917 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35082357 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35082357 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35082357 |
| 63 | Hypertensive crisis (HP:0100735) | 2.31407650 |
| 64 | Meningitis (HP:0001287) | 2.30105019 |
| 65 | Optic neuritis (HP:0100653) | 2.27877234 |
| 66 | Retrobulbar optic neuritis (HP:0100654) | 2.27877234 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.27763446 |
| 68 | Hypertriglyceridemia (HP:0002155) | 2.25499670 |
| 69 | Reticulocytopenia (HP:0001896) | 2.24313496 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 2.23355488 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 2.21283195 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.19602623 |
| 73 | Epistaxis (HP:0000421) | 2.18935300 |
| 74 | Stomatitis (HP:0010280) | 2.18481070 |
| 75 | Cellulitis (HP:0100658) | 2.18408588 |
| 76 | Hypochromic anemia (HP:0001931) | 2.17438650 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.16077494 |
| 78 | Spondylolisthesis (HP:0003302) | 2.15185673 |
| 79 | Cheilitis (HP:0100825) | 2.14706005 |
| 80 | Recurrent lower respiratory tract infections (HP:0002783) | 2.13811591 |
| 81 | Purpura (HP:0000979) | 2.11752351 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.09086222 |
| 83 | Abnormality of the prostate (HP:0008775) | 2.08847916 |
| 84 | Skin ulcer (HP:0200042) | 2.08681491 |
| 85 | Peritonitis (HP:0002586) | 2.07908485 |
| 86 | Hemoptysis (HP:0002105) | 2.06517495 |
| 87 | Leukocytosis (HP:0001974) | 2.05246330 |
| 88 | Poor head control (HP:0002421) | 2.04328250 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 2.04309054 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 2.03104041 |
| 91 | Abnormality of male internal genitalia (HP:0000022) | 2.02922772 |
| 92 | Joint stiffness (HP:0001387) | 2.02656544 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.02360116 |
| 94 | Polygenic inheritance (HP:0010982) | 2.02188653 |
| 95 | Colitis (HP:0002583) | 2.02049702 |
| 96 | Prolonged neonatal jaundice (HP:0006579) | 2.01969208 |
| 97 | Alopecia of scalp (HP:0002293) | 2.01353739 |
| 98 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00895750 |
| 99 | Polycythemia (HP:0001901) | 1.99661949 |
| 100 | Microcytic anemia (HP:0001935) | 1.97303703 |
| 101 | Abnormality of T cell number (HP:0011839) | 1.96563005 |
| 102 | Myocardial infarction (HP:0001658) | 1.93436058 |
| 103 | Spontaneous hematomas (HP:0007420) | 1.93296475 |
| 104 | Muscle fiber atrophy (HP:0100295) | 1.92145376 |
| 105 | Anorexia (HP:0002039) | 1.92104355 |
| 106 | Gingival bleeding (HP:0000225) | 1.91793346 |
| 107 | Pulmonary infiltrates (HP:0002113) | 1.91336894 |
| 108 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90875359 |
| 109 | Increased serum ferritin (HP:0003281) | 1.88842753 |
| 110 | Tetraparesis (HP:0002273) | 1.88745133 |
| 111 | Asymmetric septal hypertrophy (HP:0001670) | 1.88184062 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88088312 |
| 113 | Chest pain (HP:0100749) | 1.87651022 |
| 114 | Eosinophilia (HP:0001880) | 1.85163884 |
| 115 | Increased IgE level (HP:0003212) | 1.85076262 |
| 116 | Granulocytopenia (HP:0001913) | 1.84492537 |
| 117 | Nausea (HP:0002018) | 1.83850327 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.82852841 |
| 119 | Glomerulopathy (HP:0100820) | 1.82123291 |
| 120 | Axonal loss (HP:0003447) | 1.81779778 |
| 121 | Increased connective tissue (HP:0009025) | 1.81575476 |
| 122 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80481355 |
| 123 | Type I transferrin isoform profile (HP:0003642) | 1.80181663 |
| 124 | Cervical subluxation (HP:0003308) | 1.79685897 |
| 125 | Episodic fever (HP:0001954) | 1.78592652 |
| 126 | Abnormality of the pericardium (HP:0001697) | 1.78311086 |
| 127 | Atrophic scars (HP:0001075) | 1.76010377 |
| 128 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75333597 |
| 129 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.75018359 |
| 130 | Osteolytic defects of the hand bones (HP:0009699) | 1.75018359 |
| 131 | Premature loss of primary teeth (HP:0006323) | 1.70168137 |
| 132 | Abnormality of complement system (HP:0005339) | 1.68105680 |
| 133 | Dilatation of the ascending aorta (HP:0005111) | 1.68026211 |
| 134 | Nuclear cataract (HP:0100018) | 1.67131685 |
| 135 | Encephalitis (HP:0002383) | 1.66246185 |
| 136 | Osteomyelitis (HP:0002754) | 1.65588835 |
| 137 | Skin rash (HP:0000988) | 1.65517376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIM2 | 3.90287357 |
| 2 | NME2 | 2.92483131 |
| 3 | TBK1 | 2.74369028 |
| 4 | TYK2 | 2.59241056 |
| 5 | MAP3K14 | 2.47849851 |
| 6 | BLK | 2.46138104 |
| 7 | MAP4K1 | 2.33739106 |
| 8 | JAK3 | 2.24277928 |
| 9 | MAP3K11 | 2.22658923 |
| 10 | KIT | 2.21170525 |
| 11 | IKBKE | 2.16397286 |
| 12 | ERN1 | 2.11103649 |
| 13 | IRAK4 | 2.01231766 |
| 14 | PRPF4B | 1.98869139 |
| 15 | MATK | 1.93945346 |
| 16 | IKBKB | 1.93644156 |
| 17 | CSK | 1.83436302 |
| 18 | MAP3K6 | 1.77294681 |
| 19 | PIM1 | 1.70078177 |
| 20 | KDR | 1.66347324 |
| 21 | ZAP70 | 1.62388775 |
| 22 | MAPK15 | 1.59298886 |
| 23 | TEC | 1.57157036 |
| 24 | TRPM7 | 1.56335023 |
| 25 | GRK6 | 1.51259228 |
| 26 | DDR2 | 1.50585481 |
| 27 | RPS6KA4 | 1.45768849 |
| 28 | LIMK1 | 1.45249034 |
| 29 | FES | 1.45125476 |
| 30 | TESK2 | 1.41282977 |
| 31 | TXK | 1.40736826 |
| 32 | BTK | 1.38852953 |
| 33 | MOS | 1.35479442 |
| 34 | BMX | 1.29210836 |
| 35 | PBK | 1.29006569 |
| 36 | IRAK3 | 1.27536674 |
| 37 | FLT3 | 1.27442337 |
| 38 | TAOK1 | 1.25192014 |
| 39 | JAK1 | 1.22863888 |
| 40 | TESK1 | 1.19996488 |
| 41 | MAP2K3 | 1.18113483 |
| 42 | LRRK2 | 1.11066830 |
| 43 | VRK2 | 1.09847644 |
| 44 | LYN | 1.09824721 |
| 45 | GRK7 | 1.08494666 |
| 46 | DAPK1 | 1.08453030 |
| 47 | SYK | 1.06641995 |
| 48 | YES1 | 1.06278082 |
| 49 | TRIB3 | 1.05483382 |
| 50 | FGFR4 | 1.03603646 |
| 51 | DYRK1B | 1.03527784 |
| 52 | SIK1 | 1.02871423 |
| 53 | TNK2 | 1.02794616 |
| 54 | CDK6 | 1.02482183 |
| 55 | ICK | 1.00368439 |
| 56 | CHUK | 1.00133712 |
| 57 | SMG1 | 0.99284296 |
| 58 | NEK9 | 0.97618867 |
| 59 | MAP3K1 | 0.97029919 |
| 60 | ABL2 | 0.96429876 |
| 61 | RIPK4 | 0.93891639 |
| 62 | LCK | 0.92767504 |
| 63 | MAP3K13 | 0.92264726 |
| 64 | EPHA2 | 0.91866297 |
| 65 | STK10 | 0.89593805 |
| 66 | MAPK11 | 0.88936198 |
| 67 | TTN | 0.88573647 |
| 68 | EIF2AK3 | 0.88234594 |
| 69 | ACVR1B | 0.87437291 |
| 70 | CDK7 | 0.87054804 |
| 71 | MAPKAPK3 | 0.87041222 |
| 72 | BCKDK | 0.86480664 |
| 73 | STK16 | 0.86443487 |
| 74 | CSF1R | 0.84889500 |
| 75 | RPS6KA6 | 0.84668517 |
| 76 | TGFBR2 | 0.83866936 |
| 77 | EIF2AK1 | 0.80700680 |
| 78 | FGR | 0.74952751 |
| 79 | RPS6KL1 | 0.73376770 |
| 80 | RPS6KC1 | 0.73376770 |
| 81 | JAK2 | 0.73167232 |
| 82 | EIF2AK2 | 0.73077721 |
| 83 | EPHB2 | 0.72983516 |
| 84 | PINK1 | 0.72379904 |
| 85 | MST4 | 0.70508737 |
| 86 | STK4 | 0.70214525 |
| 87 | DYRK3 | 0.67916066 |
| 88 | PDPK1 | 0.67332809 |
| 89 | SCYL2 | 0.65805389 |
| 90 | HCK | 0.65300666 |
| 91 | CDC42BPA | 0.65256857 |
| 92 | TGFBR1 | 0.64099460 |
| 93 | PRKG2 | 0.62899670 |
| 94 | PAK4 | 0.61122451 |
| 95 | PTK6 | 0.59102620 |
| 96 | MAP3K3 | 0.58485427 |
| 97 | DAPK3 | 0.57823406 |
| 98 | MAPKAPK2 | 0.57239691 |
| 99 | TAOK2 | 0.57051820 |
| 100 | LMTK2 | 0.56218054 |
| 101 | PRKCD | 0.56150684 |
| 102 | VRK1 | 0.51815265 |
| 103 | MST1R | 0.51157053 |
| 104 | BUB1 | 0.50892508 |
| 105 | PRKD2 | 0.50302065 |
| 106 | ABL1 | 0.50004216 |
| 107 | MAP2K2 | 0.49902069 |
| 108 | MAPK7 | 0.49665063 |
| 109 | TIE1 | 0.49516773 |
| 110 | ILK | 0.48965488 |
| 111 | SIK3 | 0.48438462 |
| 112 | HIPK2 | 0.48119637 |
| 113 | RPS6KA2 | 0.48002974 |
| 114 | NLK | 0.47647058 |
| 115 | PAK1 | 0.46805370 |
| 116 | TLK1 | 0.46133835 |
| 117 | EPHB1 | 0.46066514 |
| 118 | RPS6KB2 | 0.45515749 |
| 119 | RAF1 | 0.45432281 |
| 120 | MARK3 | 0.45343717 |
| 121 | PDK1 | 0.44517912 |
| 122 | WEE1 | 0.44227333 |
| 123 | MAP3K8 | 0.44104409 |
| 124 | TAOK3 | 0.43641527 |
| 125 | CDK4 | 0.42929151 |
| 126 | MYLK | 0.42615154 |
| 127 | MAP2K6 | 0.42594206 |
| 128 | PIK3CG | 0.42144307 |
| 129 | ARAF | 0.42078042 |
| 130 | BMPR2 | 0.41846675 |
| 131 | MAPK12 | 0.41506892 |
| 132 | MAP3K5 | 0.40466268 |
| 133 | RIPK1 | 0.39930238 |
| 134 | ATR | 0.39929501 |
| 135 | BRAF | 0.39808979 |
| 136 | PDGFRA | 0.39535801 |
| 137 | MAPK4 | 0.39501577 |
| 138 | ITK | 0.39415469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 2.80730788 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.72821045 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.50677260 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.35422455 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34922005 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.34910718 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.29421555 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.25939803 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.21199374 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.11743524 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09462349 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.06982603 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.02880082 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01441712 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82124458 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80810755 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76752299 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70634224 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70584021 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.51517757 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50288032 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49158452 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.46710610 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.45901211 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.43720936 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.32607529 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31766022 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.31187285 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30951426 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.28232179 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27300549 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.27093236 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26820576 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.26745595 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24473624 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24027556 |
| 37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.20930852 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19655930 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.19409693 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17974204 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.15918076 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15745762 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14296228 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13131017 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10968857 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10653826 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.10086574 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09936150 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08863053 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.07970777 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06714123 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04910592 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99050433 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98901050 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95713213 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.94417376 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92509555 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91721426 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.91222875 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90539657 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84693313 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84641537 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.81123065 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81066814 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80400564 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79685803 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78559138 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74668384 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74546725 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.72625715 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.71661224 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69404425 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68622385 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66311001 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.65528954 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63868444 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63775371 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63583261 |
| 79 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63305840 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62819024 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61700385 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60759302 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60474330 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59957801 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59351091 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.58813842 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58453600 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56930501 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56076724 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55751138 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55704666 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55370510 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54708523 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54132664 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53278100 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.50257704 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46997244 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45650947 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45121758 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44896995 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44074615 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43761376 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42826175 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41284336 |
| 105 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38587726 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38559761 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38322934 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37997579 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.37965741 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37200044 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36763706 |
| 112 | Protein export_Homo sapiens_hsa03060 | 0.36510647 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35152383 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34758350 |
| 115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34085072 |
| 116 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.34024915 |
| 117 | RNA polymerase_Homo sapiens_hsa03020 | 0.33875934 |
| 118 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.33750957 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33314233 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33016166 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32304659 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32285782 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.31644528 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31603533 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.31314241 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.31185968 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29991349 |

